TFX Q3 2024 Earnings — Teleflex Incorporated Revenue & Financial Results | Market Cap Arena

TFXTeleflex Incorporated

$5B

Q3 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$764M+2.4% YoY

Gross Profit

$430M56.3% margin

Operating Income

$149M19.5% margin

Net Income

$111M14.5% margin

EPS (Diluted)

$2.36

QoQ Revenue Growth

+2.0%

Cash Flow

Operating Cash Flow

$231M

Free Cash Flow

$210M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$7.5B

Total Liabilities

$3.0B

Stockholders' Equity

$4.5B

Cash & Equivalents

$243M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$764M	$746M	+2.4%
Gross Profit	$430M	$416M	+3.3%
Operating Income	$149M	$165M	-9.7%
Net Income	$111M	$137M	-19.1%

Revenue Segments

Vascular Access

$181M27%

Interventional

$150M22%

Surgical

$112M16%

Anesthesia

$101M15%

Interventional Urology

$83M12%

Other

$55M8%

Geographic Segments

Americas Segment

$433M57%

EMEA

$150M20%

Asia

$98M13%

Oem

$83M11%